185 related articles for article (PubMed ID: 28119492)
21. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients.
Djabiri F; Caillat-Zucman S; Gajdos P; Jaïs JP; Gomez L; Khalil I; Charron D; Bach JF; Garchon HJ
J Autoimmun; 1997 Aug; 10(4):407-13. PubMed ID: 9237805
[TBL] [Abstract][Full Text] [Related]
22. HLA-DQ restriction fragment length polymorphisms in myasthenia gravis.
Bell JI; Steinman L; Toyka K; McDevitt HO
Ann N Y Acad Sci; 1987; 505():382-7. PubMed ID: 2891337
[No Abstract] [Full Text] [Related]
23. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
24. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis.
Huang DR; Pirskanen R; Matell G; Lefvert AK
J Neuroimmunol; 1999 Feb; 94(1-2):165-71. PubMed ID: 10376950
[TBL] [Abstract][Full Text] [Related]
25. A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan.
Shinomiya N; Nomura Y; Segawa M
Clin Immunol; 2004 Feb; 110(2):154-8. PubMed ID: 15003812
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis.
Isshiki Y; Mimura O; Gomi F
Jpn J Ophthalmol; 2020 Nov; 64(6):628-634. PubMed ID: 32936398
[TBL] [Abstract][Full Text] [Related]
27. A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes.
Li H; Groop L; Nilsson A; Weng J; Tuomi T
J Clin Endocrinol Metab; 2003 Jun; 88(6):2767-74. PubMed ID: 12788886
[TBL] [Abstract][Full Text] [Related]
28. DQA1 and DQB1 association and nasal polyposis.
Fajardo-Dolci G; Solorio-Abreu J; Romero-Alvarez JC; Zavaleta-Villa B; Cerezo-Camacho O; Jiménez-Lucio R; Olivo-Díaz A
Otolaryngol Head Neck Surg; 2006 Aug; 135(2):243-7. PubMed ID: 16890076
[TBL] [Abstract][Full Text] [Related]
29. No association of the HLA-DQ alleles with myasthenia gravis in Cuban patients.
Sylvia T; Samuel M; Luis G; Zuzet M
Hum Immunol; 2013 Aug; 74(8):983-5. PubMed ID: 23628390
[TBL] [Abstract][Full Text] [Related]
30. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
[TBL] [Abstract][Full Text] [Related]
31. Rare Co-occurrence of Ocular Myasthenia Gravis and Thyroid-Associated Orbitopathy (Ophthalmopathy) in an Individual With Hypothyroidism.
An R; Li Y; Yang B; Wang H; Xu Y
Front Endocrinol (Lausanne); 2018; 9():801. PubMed ID: 30809198
[TBL] [Abstract][Full Text] [Related]
32. A genome-wide association study of myasthenia gravis.
Renton AE; Pliner HA; Provenzano C; Evoli A; Ricciardi R; Nalls MA; Marangi G; Abramzon Y; Arepalli S; Chong S; Hernandez DG; Johnson JO; Bartoccioni E; Scuderi F; Maestri M; Gibbs JR; Errichiello E; Chiò A; Restagno G; Sabatelli M; Macek M; Scholz SW; Corse A; Chaudhry V; Benatar M; Barohn RJ; McVey A; Pasnoor M; Dimachkie MM; Rowin J; Kissel J; Freimer M; Kaminski HJ; Sanders DB; Lipscomb B; Massey JM; Chopra M; Howard JF; Koopman WJ; Nicolle MW; Pascuzzi RM; Pestronk A; Wulf C; Florence J; Blackmore D; Soloway A; Siddiqi Z; Muppidi S; Wolfe G; Richman D; Mezei MM; Jiwa T; Oger J; Drachman DB; Traynor BJ
JAMA Neurol; 2015 Apr; 72(4):396-404. PubMed ID: 25643325
[TBL] [Abstract][Full Text] [Related]
33. Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling.
Hjelmström P; DeWeese-Scott C; Penzotti JE; Lybrand TP; Sanjeevi CB
J Neuroimmunol; 1998 May; 85(1):102-5. PubMed ID: 9627003
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
35. [The study on human leucocyte antigen DQ region genes polymorphism in unexplained habitual abortion patients].
Lin Q; Lu P; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2001 May; 36(5):293-5. PubMed ID: 11783381
[TBL] [Abstract][Full Text] [Related]
36. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
[TBL] [Abstract][Full Text] [Related]
37. [Study on human leucocyte antigen-DQ region gene polymorphism in cases of habitual abortion with anticardiolipin antibody].
Lin Q; Lu P; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):208-11. PubMed ID: 11776160
[TBL] [Abstract][Full Text] [Related]
38. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
Guan YZ; Cui LY; Liu MS; Niu JW
Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
[TBL] [Abstract][Full Text] [Related]
39. Oxidative modifications of blood serum proteins in myasthenia gravis.
Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I
J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335
[TBL] [Abstract][Full Text] [Related]
40. [Association of TNF-α gene polymorphisms with Graves disease susceptibility and early course thyroid stimulating hormone receptor antibody level in Chinese Han population in Anhui region].
Pan TR; Xing SM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):347-51. PubMed ID: 22678805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
